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Abstract 
The majority of protozoan myosins I possess tail domains composed of three distinct and conserved regions of sequence, referred to as tail homology 
regions 1,2 and 3 (TH .I, TH .2 and TH .3). While the N-terminal _ half of the tail (corresponding to TH* 1) has been implicated in membrane binding, 
all or some portion of the C-terminal -half of the tail (corresponding to TH.2 plus TH.3) has been implicated in binding to F-actin in a 
nucleo~d~~sensiti~e fashion. Here we show, using fusion proteins containing portions of the Dictyo~fe~~~ myosin IC (myoC) tail domain and 
F-actin s~~en~tion assays, that the ability of the myoC tail to bind to actin resides entirely within the glycine- and proline-rich TH.2 domain. 
The src-like TH.3 domain does not bind to actin, nor does it augment he binding properties of theTH.2 domain. In addition to defining more preciseb 
the location of the actin binding site in the tail domain of a protozoan myosin I, these results have implications for the function of the src-like TH.3 
domain in myosins I and other proteins. 
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1. introduction 
The myosin superfamily contains, in addition to con- 
ventional two-headed myosins (myosin II), a growing 
family of unconventional myosins (for reviews, see 
(l-51). All of these myosins share an -80 kDa motor 
domain, which corresponds to the globular head or 
subfragment 1 of muscle myosin. For the unconven- 
tional myosins, this motor domain is attached to a vari- 
ety of carboxyl-terminal domains (in one case there is 
also an N-terminal, kinase-like extension [6]), The func- 
tional s~cial~ation of these unconventional myosins 
presumably resides within their distinct C-terminal do- 
mains, which serve to link the motor domain to various 
cellular structures (i.e. cargo). The identification of these 
tail domain ligands, and the correlation of the biochem- 
ical properties of tail domains (e.g. the binding of actin, 
membranes, calmodulin) with their primary structure, 
will be very important aspects of myosin structure-func- 
tion analysis. 
In the case of the protozoan myosins I, the majority 
of isoforms sequenced to date (the so called ‘classic’ 
myosins I) possess three distinct and conserved regions 
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’ In Acunrhomoeba myosin IC and Dictyostelium myoD the TH.3 do- 
main is slightly internal, splitting the TH.2 domain into two portions. 
of sequence within their -45 kDa tail domains (tail ho- 
mology regions 1,2 and 3; TH. 1, TH.2 and TH.3, respec- 
tively [7-lo]). TH.1 spans the N-terminal -210 residues 
of the tail, is -60% conserved (exact matches plus con- 
servative substitutions) between the various isoforms, 
and possesses a strong net positive charge ( + 15 to 
+ 30). TH.2 spans the central - 180 residues of the tail 
and is striking in its high content of glycine, proline and 
either alanine or glutamine residues (these residues usu- 
ally comprise - 75% of the total residues in TH.2). TH.2 
domains also have a strong net positive charge. While the 
sequences of TH.2 domains from different isoforms can 
not be aligned with each other in any unique way, they 
all share this unusual composition and net positive 
charge. TH.3 spans the C-terminal -53 residues of the 
tail”, is -75% conserved between isoforms, and is also 
found in a large and diverse family of proteins, including 
all non-receptor tyrosine kinases (like pp60 src, where 
this sequence. is known in the literature as src homology 
region 3 or SH3), several actin binding proteins (e.g. 
yeast ABPl and fodrin), and many proteins involved in 
signal transduction (eg. phospholipase C, and SH2/SH3 
adaptor proteins like Grb2) (for review see [1 l-131). 
Biochemical analyses of proteolytic fragments gener- 
ated from ~c~~~~~~e~u myosin IA 1141 and fragments 
of Acanthumoeba myosin IC expressed in E. coli as 
B-galactosidase fusion proteins [ 151 have implicated the 
N-terminal -half of the tail, corresponding to TH.1, in 
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the binding of myosins 1 to anionic phospholipid mem- 
branes. For these same two myosin I isoforms, data have 
also been presented which show that the C-terminal 
-half of the tail binds to F-a&in in a nucleotide- 
insensitive fashion. In the first study [ 161, a chymotryptic 
fragment of Aca~thamoeba myosin IA that corresponds 
to the C-terminal - 30 kDa of the heavy chain was found 
to bind to F-actin at low ionic strength with a KD of - 200 
nM, both with and without Mg*‘ATP. The sequence of 
the myosin IA heavy chain has not been determined, 
however, so it is not known what primary sequences 
form this actin binding site. Nevertheless, it should be 
noted that amino acid analysis of this 30 kDa fragment 
revealed a high content of glycine and proline residues 
[16], suggesting that it probabiy contained a si~ificant 
portion of the TH.2 domain. In the second study [15], a 
/Lgalactosidase fusion protein containing the TH.2 and 
TH.3 domains of Acanthamoeba myosin IC was found 
to bind to F-actin, although the quantitation of this bind- 
ing was made difficult by the high background binding 
by&galactosidase alone, and by the tetrameric nature of 
the fusion protein. This study also showed that a fusion 
protein containing just TH-3 did not bind to F-actin, 
suggesting that the binding site resided solely within 
TH.2. Fusion proteins containing just the TH.2 domain 
also did not bind to actin, however, leading to the equally 
plausible conclusion that TH.2 and TH.3 are both re- 
quired to form a functional actin binding site. Alterna- 
tively, either or both of the TH.2 and TH.3 domains 
might bind to F-actin in the context of native myosin IC, 
but when these domains are expressed as separate fusion 
proteins, they might not fold properly. 
In this study we have expressed portions of the 
Dictyostelium myoC tail domain (another of the ‘classic’ 
myosins I) as glutathione-S-transferase (GST) fusion 
proteins and analyzed their interaction with F-actin by 
sedimentation assay. The results show that a fusion pro- 
tein containing TH.2 and TH.3 binds to F-actin in a 
nucleotide insensitive fashion with a Kr, of -250 nM (in 
low ionic strength), that a fusion protein containing just 
TH.3 does not bind to actin, and that a fusion protein 
containing just TH.2 binds to actin with essentially the 
same affinity as the fusion protein containing both TH.2 
and TH.3. In addition to localizing the actin binding site 
to the glycine- and proline-rich TH.2 domain, this study 
sheds light on the possible functions of src-like TH.3 
domains and SH3 domains in general. 
2. Materials and methods 
2.1. Vector constructions 
A genomic clone that contains - 90% of the coding sequence for the 
Dicfyostelium yoC heavy chain (beginning at a position 11 amino 
acids N-terminal of the C in GESGAKT and ending 3’ to the stop 
codon), together with the corresponding DNA/protein sequence, was 
a generous gift of Dr. Margaret A. Titus (Duke University, Durham, 
NC). MyoC tail domain fusion proteins were expressed using the vec- 
tor, pGEX-3X (Pharmacia LKB Biotechnology), in which the myoC 
tail fragments are fused to the C-terminus of glutathione S-transferase 
(GST; - 26 kDa). To simplify the numbering system (since the complete 
sequence of myoC is not available), we have numbered the myoC tail 
domain residues l-444, beginning at the head/tail junction. Based on 
this numbering system, TH.1 corresponds to residues l-21 3, TH.2 to 
residues 214-391, and TH.3 to residues 392444. To express a fusion 
protein containing both TH.2 and TH.3 (GST-TH.2/TH.3), a 745 bp 
DruI fra~ent which encodes the C-terminal 248 amino acids of the 
myoC tail (from residue 197 to 444) was converted to EcoRI ends by 
linker addition and subcloned into EcoRI-cut pGEX-3X. This fusion 
protein contains the entire TH.2 and TH.3 domains, as well as the last 
16 residues (or - 7%) of the TH. 1 domain. To express a fusion protein 
containing just TH.2 (GST-TH.2), a 598 bp DraI-RsaI fragment en- 
coding tail residues 1977395 was converted to EcoRI ends by linker 
addition and cloned into EcoRI-cut pGEX-3X. This fusion protein 
contains the entire TH.2 domain plus the C-terminal 16 residues (or 
-7%) of TH.1 and the N-terminal 3 residues (or -6%) of TH.3. 
To express a fusion protein containing just the TH.3 domain (GST-- 
TH,3), PCR was used to amplify this region of the myoC tail. Spe- 
cifically, a 5’ primer containing a BaPnHl restriction site 
(CTAGGATCCTCGCTCTTTACGAGTACGACC) and a 3’ primer 
contaw EcoRI site and the stop codon (CTAGAATTC- 
TTAAAmTGTTGAACATAATTTGAAGG) were used to amplify a 
plasmid subclone containing the entire tail of myoC. The fragment 
obtained, which encodes the C-terminal 53 residues of the heavy chain 
(392444) (i.e. the entire TH.3 domain), was authenticated by DNA 
sequencing, cut with BarnHI and EcoRI, and cloned into pGEX-3X 
that had been cut with these two enzymes. 
2.2. Expression Ed pur~~~ation of fw&n proteins 
E. coil strain DHSa, carrying either the vector alone (for expression 
of unfused GST) or the expression plasmids described above, was 
grown to saturation, diluted 1:lO in LB media (with 50 &/ml ampi- 
cillin), and grown at 30°C to OD -0.8 (600 nm). At this point, IPTG 
was added to a final concentration of 1 mM to induce protein expres- 
sion. After incubation for 3 h at 3O’C , the cells were pelleted and the 
pellets were resuspended at 4°C in PBS (150 mM sodium chloride, 20 
mM sodium phosphate, pH 7.3) containing 2 mM DTT, 1% (v/v) Triton 
X-100. and protease inhibitors (pepstatin and leupeptin (1 &ml each), 
aprotinin and TAME (2 pg/ml each), I mM PMSF, 10 pg/ml AEBSF) 
at a ratio of 5 ml buffer per g of cells. The cells were then lyzed by 
sonication (three times 20 s, 50% duty cycle, 3.5 W) using a Branson 
sonic&or and a model C3 horn. The lysates were clarified by centrifu- 
gation (10,000 x g, 15 min, 4°C) and the supernatants were applied to 
a GST-Sepharose 4B column (Pharmacia LKB). The column was 
washed extensively with PBS and fusion proteins were eluted with 
50 mM Tris-HCl (pH 8.0) containing 8 mM reduced glutathione. The 
peak of fusion protein (as identified by SDS-PAGE) was dialyzed 
against the appropriate actin binding buffer (see below). Protein con- 
centrations were determined by the Bio-Rad protein assay using bovine 
serum albumin as a standard, and molarities were calculated based on 
molecular weights estimated from SDS-PAGE mobilities. Rabbit skel- 
etal muscle actin, which was a generous gift of Dr. Shannon Holliday 
(NHLBI, NIH, Bethesda, MD). was purified according to Spudich and 
Watt [17], followed by gel-filtration on Sephadex G-200. The concen- 
tration of actin was determined from its molar extinction coefficient. 
2.3. Actin binding assays 
The binding of GST, GST-TH.2/TH.3, GST-TH.2, and GST-TH.3 
to F-actin was measured using an F-actin sedimentation assay. All 
binding assays were performed using a constant final concentration of 
F-a&n (2 iM) and varying final concentrations of fusion protein 
(0.5 to 7 uM). The standard binding assay condition was 10 mM Tris- 
HCl (pH 7.5) 2 mM MgCl,, 0.2 mM ATP, and 0.1 mM DTT. To 
prevent he loss of fusion proteins by adsorption onto the walls of the 
centrifuge tubes, the tubes were siliconized and fatty acid-free BSA (at 
a final concentration of 0.2 mg/ml) was included in all binding assay 
buffers. Some binding assays also contained either KC1 or ATP at final 
concentrations of 30 mM and 2 mM, respectively. After mixing F-actin 
and the fusion protein, the samples were incubated for 30 min at room 
temperature and centrifuged at 65,000 rpm (- 160,000 x g) for 20 min 
at 20°C in a TL-100 ultracentrifuge (Beckman). Following centrifuga- 
tion, the supernatant was removed to a separate tube and the pellet was 
G. Jung, J.A. GOfer IIIIFEBS Letters 342 (1994) 197-202 
resuspended in a volume of binding buffer equal to that of the superna- 
tant. Both samples were mixed with an equal volume of 2 x SDS- 
PAGE sample buffer and boiled for 5 min. The amount of fusion 
protein bound was determined by SDS-PAGE analysis of both super- 
natants and pellets. The actual amount of fusion protein in these sam- 
ples was calculated based on quantitative densitometry of gels stained 
with Coomassie blue and scanned using a laser densitometer (LKB). 
Purified fusion proteins were used as internal standards. For the data 
presented in Fig. 3, the amount of fusion protein bound was determined 
based on the appearance of fusion protein in the pellet (as opposed to 
depletion of fusion protein from the supematant). Calculation of the 
amount bound based on depletion of fusion protein from the supema- 
tant gave, as expected, very similar values. Less than 5% of each fusion 
protein sedimented in the absence of F-actin, and the binding data were 
corrected for the exact amount. The binding data were directly fitted 
using a non-linear least squares fitting routine (DEC 10 MLAB pro- 
gram, DCRT, NIH). It was assumed that the GST fusion proteins are 
monomeric, which is consistent with previous reports [ 181 and with the 
lack of obvious cooperativity in the binding data, and that the fusion 
proteins bind to actin in a 1:l molar ratio (i.e. single site equilibrium). 
3. Results 
3.1. Expression and p~rl~cation of ANT-myo~ tail 
domain lesson proteins 
The tail domain of Dictyosteh’um yoC shows a high 
degree of similarity to the tail domains of other ‘classic’ 
myosins I, possessing all three tail homology regions 
(TH. 1, TH.2 and TH.3) described previously for myosins 
IB and IC from Acanthamoeba nd myoB and myoD 
from Dictyoste~ium (Fig. 1). Like these myosins, the 
TH.2 domain of myoC is rich in glycine, proline and 
alanine residues (1 I%, 28%, and 16%, respectively), and 
possesses a strong net positive change (+21). Further- 
more, the src-like TH.3 domain of myoC is 70% and 73% 
similar to the TH.3 domains of Dictyostelium myoB and 
myoD, respectively. Previous biochemical studies of 
other classic protozoan myosin I isoforms have impli- 
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cated all or some portion of the TH.2 plus TH.3 domains 
in binding to F-actin in a nucleotide-insensitive fashion 
[15,16]. To further dissect this actin binding site, GST- 
myoC tail domain fusion proteins containing TH.2 plus 
TH.3 (GST-TH.2/TH.3), TII.2 alone (GST-TH+2), and 
TH.3 alone (GST-TH+3) (Fig. 1) were expressed and 
purified. Fig. 2 shows a Coomassie blue-stained gel of 
these fusion proteins (along with unfused GST) follow- 
ing their purification on glutathione-Sepharose 4B. The 
estimated molecular masses of GST, GST-TH*2/TH.3, 
GST-TH.2, and GST-TH,3 were 265852 and 32 kDa, 
respectively. All of these proteins were greater then 98% 
pure as judged by SDS-PAGE. The GST-TH.3 fusion 
protein routinely appeared as a close doublet with the 
upper band corresponding in size to the full-sized fusion 
protein. Efforts to separate the intact fusion protein from 
the apparent proteolytic degradation product (which 
varied from l&35% of the total) were unsuccessful, so 
binding assays were done with the mixture of both pep- 
tides. 
3.2. Acfin binding assays 
The interaction of these GST-myoC tail domain fu- 
sion proteins with F-actin was determined using F-actin 
sedimentation assays. Since GST alone showed no signif- 
icant binding to actin, binding assays were done using 
the intact fusion proteins, i.e. no effort was made to 
cleave off the GST portion of the fusion proteins. As 
described in section 2, all binding assays were performed 
using a constant final concentration of F-actin (2 PM) 
and varying final concentrations of fusion proteins (0.5- 
7.0 PM). Fig. 3 shows the binding curves for GST-TH*2/ 
TH.3, GST-TH.2, and GST-TH.3, plotted as the con- 
centration of free fusion protein vs. the fractional satura- 
tion of F-actin in the assay (a value of 1.0 equals 2 ,uM 
Actin Membrane Actin 
Binding I Binding Binding II 
-by 
GST-lH.2lTH.3 
GST-TH.2 a 
GST-TH.3 ar 
GST rq-r) 
Fig. 1. Scheme depicting the structure of the myoC heavy chain, its relationship to previously characterized myosin I heavy chains, and the structure 
of the GST-myoC tail domain fusion proteins used in the actin binding assays. 
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Fig. 2. Coomassie blue-stained gel of purified GST fusion proteins 
resolved by SDS-PAGE. 
bound peptide). Under standard assay conditions, the 
GST-TH.2/TH.3 fusion protein bound to F-actin with 
high affinity (Kp = 260 f 20 nM) (Fig. 3A, squares). The 
maximal binding observed was 0.95 mol of GST-TH.2/ 
TH.3 per mol of actin subunit. In the presence of 30 mM 
KCl, the binding of GST-TH.2/TH.3 to actin was 
slightly weaker (&, = 570 f 20 nM) (Fig. 3A, triangles) 
and the maximal binding observed was 0.9 mol of fusion 
protein per mol of actin. The addition of 2 mM 
Mg’+ATP did not significantly alter the affinity of GST- 
TH.2/TH.3 for F-actin (data not shown). 
While GST-TH.2/TH.3 bound tightly to F-actin, 
GST-TH.3 showed no significant atEnity for actin (Fig. 
3A, circles), suggesting that the actin binding site resides 
entirely within TH.2. This was borne out by binding 
assays performed with GST-TH.2. Specifically, GST- 
TH.2 bound to F-actin under standard assay conditions 
with a I& of 250 + 10 nM (Fig. 3B, squares), a value 
which does not differ significantly from that obtained for 
the GST-TH.2/TH.3 fusion protein. The maximal bind- 
ing observed was 0.95 mol GST-TH.2 per mol of actin 
subunit. In the presence of 30 mM KCl, the binding of 
GST-TH.2 was again slightly weaker (& = 530 f 50 
nM) and the maximal binding observed was 0.9 mol 
GST-TH.2 per mol of actin subunit (Fig. 3B, triangles). 
Like GST-TH.2nH.3, the binding of GST-TH.2 to 
F-actin was insensitive to 2 mM M$‘ATP (data not 
shown). 
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4. Discussion 
The results presented here indicate that the tail domain 
of Dictyostelium myoC contains a nucleotide-insensitive 
actin binding site and that this site resides entirely within 
the glycine- and proline-rich sequence (TH.2). It is un- 
likely that the lack of affinity for F-actin exhibited by the 
GST-TH.3 fusion protein is due to improper folding of 
the TH.3 domain or to shielding of this domain by the 
GST moiety, since the fusion protein containing both 
TH.2 and TH.3 did not bind actin any more tightly than 
did the fusion protein containing TH.2 alone. 
The existence of this actin binding site in the tail, 
together with the nucleotide-sensitive site within the 
head, should allow myoC to crosslink actin filaments, as 
has been shown directly for purified Acanthamoeba 
myosins I [19]. It is almost certain that Dictyostelium 
myoB and myoD also possess this second actin binding 
site, not only because they possess a glycine- and-proline- 
rich TH.2 domain, but because their Mg*‘ATPase activ- 
ities display a triphasic dependence on F-actin concen- 
tration [20]. This complex kinetic behavior is thought to 
be a direct consequence of actin crosslinking by myosin 
I [19]. Light immunofluorescence performed with 
isoform-specific antibodies reveals that myoB [21], 
,5 0.8 
vi 
5 
5 0.6 
UY 
% 
c 0.4 
.g 
i 0.2 
0.0 
[Fusion Peptide& (PM) 
1 .o 
,$ 0.8 
tij 
; 
z 0.6 0 GST-TH.2 
UJ A GST-TH.Z+KCL 
ii 
c 0.4 
.o 
j 0.2 
‘%.O 1.0 2.0 3.0 4.0 5.0 6.0 
IFusion PeptidelFREE (uM) 
Fig. 3. Actin binding data plotted as the fractional saturation of F-actin 
vs. the concentration of free fusion protein. All assays contained a 
constant amount of F-actin (2 ,uM) and varying amounts of fusion 
protein. At a value of 1 .O, there is 2 PM bound fusion protein in a 1: 1 
molar complex with actin subunits. 
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myoC2, and myoD [lo] are concentrated in actin-rich 
cortical regions such as pseudopodia and lamellopodia. 
In these regions, actin exists as short filaments arranged 
in an isotropic network or meshwork [22,23]. In this 
organizational state, activated (i.e. heavy chain 
phosphorylated) myosins I should produce a contractile 
or collapsing force on the actin gel, as has been shown 
in vitro [19]. Therefore, the likelihood that these myosin 
I isoforms can act as A~-dependent actin crosslinkers, 
and that they can generate a contractile tension in the 
cortical actin meshwork, should allow them to play a 
crucial role in cell shape change, cell locomotion, and a 
host of other membrane/cytoskeletal interactions (e.g. 
phagocytosis and pinocytosis) (for review, see [24]). 
The affinities obtained here for the fusion proteins 
containing the TH.2 domain of myoC are very similar to 
the affinity of the C-terminal -30 kDa chymotryptic 
fragment of A~~~~~rnoe~ff myosin IA for actin meas- 
ured under similar conditions (-200 nM). The salt sen- 
sitivity of the interaction between this - 30 kDa fragment 
and actin was not determined. Here we found about a 
two-fold decrease in the binding constant for actin by the 
addition of 30 mM KCl. Addition of 100 mM KC1 sub- 
stantially reduced the binding of myoC tail domain fu- 
sion proteins to actin (data not shown). While we did not 
accurately determine the binding under these conditions, 
we note that in the actin-rich regions where these classic 
myosins I are con~ntrated, actin con~ntrations have 
been estimated to be of the order of 2OfL300 PM 1251. At 
these extremely high concentrations, even relatively 
weak binding at physiological ionic strength would prob- 
ably be sufficient to bind much of the myosin I to actin 
through its nucleotide-insensitive actin binding site. 
Further efforts to localize this actin binding site within 
the TH.2 domain should focus on the numerous, short, 
glycine- and-proline-rich pseudorepeats hat occur in the 
TH.2 domain of this and other classic myosins I [7-lo]. 
For example, the TH.2 domain of myoC contains two 
7-copy repeats the consensus sequences of which are 
PAPGG and PMMKKPAP. Invariably, TH.2 domains 
also possess a strong net positive charge, and these 
charges presumably play a role in binding to actin based 
on the salt sensitivity of the binding. SH3 domains have 
recently been shown to bind to certain proline-rich se- 
quences [26,27], so it will be interesting to see if the TH.3 
domain of myoC interacts si~ificantly with the TH.2 
domains from this or other classic myosin I isoforms. 
While the data presented here do not reveal what mol- 
ecule(s) the SH3-like TH.3 domain of myoC interacts 
with, they do indicate that actin is not one of these mol- 
ecules. The SH3 domain of C-abl, a src kinase relative, 
has also been reported to lack affinity for actin, but the 
data is largely anecdotal [26]. At the present ime, gener- 
‘G. Jung and J.A. Hammer III, unpublished observations. 
alizations regarding SH3-domain ligands must be formu- 
lated with caution, especially since one recently identified 
SH3 ligand, the protein 3BP1, demonstrates a strong 
selectively in its interactions with the SH3 domains from 
various src-family members [26]. Nevertheless, our re- 
sults suggest hat the localization of a GST fusion pro- 
tein that contains just the SH3 domain from phospholip- 
ase Cy to the actin cytoskeleton [28], as well as the shift 
in lo~ali~tion of the adaptor protein Grb2 from actin- 
rich membranes ruflles to the cytoplasm by SH3-loss-of- 
function mutations [28], are not due to a direct interac- 
tion between SH3 and F-actin. Rather, SH3 domains 
may interact with a common, highly conserved actin- 
associated protein. Consistent with this, the SH3 domain 
from pp60 src was recently shown to bind to paxillin, a 
protein which interacts with the ubiquitous actin binding 
protein, vinculin [29]. 
SH3 domains have recently been linked to signal 
transduction pathways mediated by ras and other 
closely-related monomeric GTPases. First, the protein, 
3BP1, which binds to the SH3 domain of C-abl, has 
homology to Bcr, N-chimearin and GAP-rho, all three 
of which have GTPase activating (GAP) activity for ras- 
related proteins [26]. Interestingly, rho and its close rela- 
tive rat are ras-related GTPases that control the organiz- 
ational state of the actin cytoskeleton [30,31]. Second, 
the adaptor protein, Grb2, which is composed almost 
entirely of two SH2 domains and a central SH3 domain, 
mediates the transference of signals from receptor tyro- 
sine kinases to ras by binding to phosphorylated tyrosine 
residues on the cytoplasmic tails of the receptors (via 
SH2) and to SOS, a nucleotide exchange factor for ras 
(via SH3) (for review, see [32]). These findings point to 
the exciting possibility that myosins I may play a role in 
ras-mediated signal transduction and that they may even 
influence the organizational state of the actin cytoskele- 
ton. The myoC tail domain fusion proteins described in 
this report would appear to fold properly and should, 
therefore, be useful for further studies designed to iden- 
tify other tail domain ligands, such as membrane-associ- 
ated myosin I docking proteins and proteins that interact 
with the src-like TH.3 domain. 
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